Evidence map›Paper›PMID 35387400›Full record

ArticleTransplant international : official journal of the European Society for Organ Transplantation2022

Donor Autonomy and Self-Sacrifice in Living Organ Donation: An Ethical Legal and Psychological Aspects of Transplantation (ELPAT) View.

Nizam Mamode, Kristof Van Assche, Lisa Burnapp, Aisling Courtney, David van Dellen, Mireille Houthoff, Hannah Maple, Greg Moorlock, Frank J M F Dor, Annette Lennerling

Open access · goldAbstract read
In one paragraph

Article in Transplant international : official journal of the European Society for Organ Transplantation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Living Donor Kidney Transplantation in Older Individuals: An Ethical Legal and Psychological Aspects of Transplantation (ELPAT) View.Transplant international : official journal of the European Society for Organ Transplantation · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 4 countries.

Nizam MamodeDepartment of Transplantation, Guys and St Thomas NHS Foundation Trust, London, United Kingdom.
Kristof Van AsscheResearch Group Personal Rights and Property Rights, University of Antwerp, Antwerp, Belgium.
Lisa BurnappDepartment of Transplantation, Guys and St Thomas NHS Foundation Trust, London, United Kingdom.
Aisling CourtneyRegional Nephrology and Transplant Unit, Belfast City Hospital, Belfast, United Kingdom.
David van DellenDepartment of Renal and Pancreas Transplantation, Manchester University NHS Foundation Trust, Manchester, United Kingdom.
Mireille HouthoffErasmus MC Transplant Institute, Department of Internal Medicine, University Medical Centre, Erasmus University Rotterdam, Rotterdam, Netherlands.
Hannah MapleDepartment of Transplantation, Guys and St Thomas NHS Foundation Trust, London, United Kingdom.
Greg MoorlockWarwick Medical School, University of Warwick, Coventry, United Kingdom.
Frank J M F DorImperial College Renal and Transplant Centre, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.
Annette LennerlingThe Transplant Centre, Sahlgrenska University Hospital, Gothenburg, Sweden.
NHS Blood and Transplant · GBErasmus MC Cancer Institute · NLImperial College Healthcare NHS Trust · GBManchester University NHS Foundation Trust · GBUniversity of Antwerp · BEUniversity of Gothenburg · SEUniversity of Warwick · GBWessex Regional Genetics Laboratory · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical teams understandably wish to minimise risks to living kidney donors undergoing surgery, but are often faced with uncertainty about the extent of risk, or donors who wish to proceed despite those risks. Here we explore how these difficult decisions may be approached and consider the conflicts between autonomy and paternalism, the place of self-sacrifice and consideration of risks and benefits. Donor autonomy should be considered as in the context of the depth and strength of feeling, understanding risk and competing influences. Discussion of risks could be improved by using absolute risk, supra-regional MDMs and including the risks to the clinical team as well as the donor. The psychological effects on the donor of poor outcomes for the untransplanted recipient should also be taken into account. There is a lack of detailed data on the risks to the donor who has significant co-morbidities.

Indexed as

Organ TransplantationTissue and Organ ProcurementHumansKidneyLiving Donorsautonomy 2kidneyliving donationrisktransplantation

Identifiers

PMID35387400
PMCPMC8979023
OpenAlexW4220742562

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.